Leyman Barbara 4
4 · SUTRO BIOPHARMA, INC. · Filed Apr 8, 2025
Insider Transaction Report
Form 4
Leyman Barbara
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-04+91,000→ 91,000 totalExercise: $0.55Exp: 2035-04-04→ Common Stock (91,000 underlying) - Award
Restricted Stock Units (RSUs)
2025-04-04+84,500→ 84,500 totalExp: 2029-03-02→ Common Stock (84,500 underlying)
Footnotes (3)
- [F1]The option vests as to 2.0833% of the total award monthly, beginning on May 4, 2025, with 100% of the award being vested and exercisable on April 4, 2029, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total award annually beginning on March 2, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.